U.S. federal trademark · Serial No. 88779170
Medical diagnostic assays for testing bodily fluids, namely, a targeted DNA and RNA sequencing assay that enables comprehensive genomic profiling of tumor samples, specifically key immunotherapy biomarkers in the nature of Tumor Mutation Burden and Microsatellite Instability
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.